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Purpose: Ehlers-Danlos syndrome type IV (EDS-IV) results from abnormal procollagen III synthesis and leads to arterial,
intestinal, and uterine rupture. The purpose of this study was to review the spectrum, management, and clinical outcome
of EDS-IV patients.
Methods:We retrospectively reviewed the clinical data of 31 patients (15 male and 16 female) with a clinical diagnosis of
EDS-IV treated over a 30-year period (1971 to 2001). Biochemical confirmationwas obtained in 24 patients, andmutation
of the COL3A1 gene was confirmed in 11 patients. The study excluded patients with other connective tissue dysplasias.
Results: The mean age at the time of diagnosis was 28.5  11 years (range, 10 to 53 years). Twenty-four patients
developed 132 vascular complications; of these, 85 were present either before or at the time of the initial evaluation, and
47 complications occurred during a median follow-up of 6.3 years (range, 0.5 to 26 years). Survival free of vascular
complications was 90% at age 20 years, 39% at 40 years, and 20% at age 60 years. Fifteen patients underwent 30 operative
interventions for vascular complications, including arterial reconstruction (n 15), simple repair or ligation (n 4), coil
embolization (n  3), splenectomy (n  2), and abdominal decompression, nephrectomy, graft thrombectomy, vein
stripping and thoracoscopy (n  1 each). Three hospital deaths occurred from exsanguinating hemorrhage: two after
operative interventions and one because of a ruptured splenic artery. Procedure-related morbidity was 46%, including a
37% incidence of postoperative bleeding and a 20% need for re-exploration. The incidence of late graft-related
complications was 40% of arterial reconstructions, including 4 anastomotic aneurysms, 1 fatal anastomotic disruption,
and 1 graft thrombosis. Patient survival was 68% at age 50 years and 35% at age 80 years. Of the 12 deaths during the
study period, 11 were associated with vascular or graft-related complications.
Conclusion: Operative mortality in patients with vascular complications of EDS-IV was not excessively high, but the
incidence of postoperative bleeding complications and late graft-related problems was significant. Despite successful
repair of vascular complications, survival was shortened because of secondary vascular or graft-related complications.
(J Vasc Surg 2005;42:98-106.)Ehlers-Danlos syndrome (EDS) is a term that encom-
passes a variety of types of inherited connective tissue
disorders.1-2 Although most patients have the classic form
with joint hypermobility, increased skin elasticity, and tis-
sue fragility, EDS comprises a heterogeneous group of
clinical syndromes with distinct inheritance, biochemical
defects, and prognostic implications.1-5 EDS type IV
(EDS-IV), the vascular or arterial-ecchymotic type, is a rare
autosomal dominant disorder resulting from mutations in
the gene (COL3A1) encoding for type III procollagen
synthesis.1-5 Different from the other forms, EDS-IV may
lead to premature death from spontaneous arterial, intesti-
nal, or uterine rupture.6-8
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98Complications of EDS-IV are rare during childhood,
but approximately 80% of patients have already experienced
at least one complication by the age of 40.8 Patients are
typically unaware of the diagnosis until they present, often
to a vascular surgeon, with spontaneous arterial rupture or
dissection. Management is challenging because of extreme
tissue fragility, and numerous reports emphasize the ex-
ceedingly high risk of massive bleeding and anastomotic
disruption with attempted operative repair.7,9-15
Because no studies have reported long-term results
after a successful operation or after watchful waiting of
existing asymptomatic vascular lesions, we conducted a
retrospective review of our experience with EDS-IV pa-
tients evaluated and treated during the last three decades.
The purpose of this study was to review the spectrum,
management, and clinical outcome in these patients.
METHODS
We used the vascular surgery and medical genetics
registries to identify 31 patients with EDS-IV who were
evaluated at theMayo Clinic between January 1, 1971, and
January 1, 2001. Clinical diagnosis was made from at least
two of four major diagnostic criteria, as defined by the
revised nosology of Villefranche, 1977: thin, translucent
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history of arterial, intestinal, or uterine fragility.2 Compre-
hensive clinical and pedigree history were obtained by
medical genetics consultation. Diagnostic confirmation in-
cluded the demonstration of structurally abnormal type III
procollagen molecules by using a culture of dermal fibro-
blasts or the presence of mutation in the COL3A1 gene.
Demographics, risk factors for atherosclerosis, clinical
presentation, and details of complications were collected
from the patients’ records. We determined the ages at the
time of the clinical diagnosis and testing, time of complica-
tion, and time of death. We attempted to ascertain whether
the complication or cause of death, or both, were associated
with EDS-IV. Operative data, early and late medical and
surgical morbidity, and mortality were recorded.
A vascular complication was defined as arterial or ve-
nous rupture, dissection, aneurysm formation, and organ
rupture. Vascular complications included asymptomatic or
incidental radiologic findings. Early perioperative period
was defined as occurring in the hospital stay without regard
to the number of days after the operation or 30 postop-
erative days.
Late follow-up data were obtained from medical
records, office visits, correspondence with referring physi-
cians, and telephone interviews. A detailed questionnaire
was mailed to evaluate the presence of late complications
and the need for secondary operative procedures. Late
mortality data were also obtained using a national death
index search. Survival curves were calculated using the
Kaplan-Meier method. The study was approved by the
Table I. Clinical features of 31 patients with Ehlers-Danlos
syndrome type IV according to the revised nosology,
Villefranche, 19972
Diagnostic clinical criteria n %
Major criteria
Easy bruising 30 97
Arterial, intestinal or uterine fragility 26 84
Thin, translucent skin 24 77
Characteristic facial features* 9 29
Minor criteria
Small joint hypermobility 18 58
Skin hyperextensibility 13 42
Spontaneous pneumothorax/hemothorax 5 16
Tendon or muscle rupture 4 13
Early-onset varicose veins 2 6
Talipes equinovarus (clubfoot) 1 3
Carotid-cavernous fistula 1 3
Family history of EDS-IV 18 58
Risk factors for atherosclerosis
Hypertension 8 26
Hyperlipidemia 4 13
Cigarette smoking 3 10
Diabetes mellitus 2 6
Coronary artery disease 1 3
EDS-IV, Ehlers-Danlos syndrome type IV.
*Characteristic facial features include thin, delicate, and pinched nose;
hollow cheeks and prominent staring eyes because of paucity of adipose
tissue.institutional review board.RESULTS
Diagnosis. Fifteen male and 16 female patients met
the diagnostic criteria summarized in Table I. Twenty-four
patients (77%) had biochemical confirmation of abnormal
procollagen III synthesis, including 11 patients who had
confirmation of COL3A1 gene mutation. Seven patients
were diagnosed solely from clinical criteria. The mean age
at the time of diagnosis was 28.5  11 years, (range, 10 to
53 years). Fourteen patients with “EDS-like connective
tissue dysplasia” were excluded from the study because they
had normal type III procollagen (n 12) or failed to meet
clinical criteria (n 2), including 11 patients with multiple
vascular problems. Of the 31 patients with EDS-IV, only
eight (26%) had an established diagnosis before they pre-
sented at our institution.
Twenty-six patients (84%) had a history of EDS-IV
complications. Survival free of any arterial, intestinal, and
uterine complication was 84% at age 20 years, 37% at 40
years, and only 4% at age 60 years (Fig 1). The most
common complication was arterial rupture (n  14), fol-
lowed by intestinal rupture (n  7) and postpartum com-
plications (n 5). A family history was positive for features
suggestive of EDS-IV in 18 patients (58%), including his-
tory of vascular complications in 15, intestinal perforation
in 7, and sudden, premature death in 5 patients. A pedigree
analysis identified 60 family members at risk, of which 32
(53%) had findings suggestive of the diagnosis.
Radiologic investigation. Twenty-nine patients (94%)
underwent noninvasive imaging studies, and 22 patients
(76%) had positive findings (Table II). The abdominal and
chest vessels were studied in 27 (87%) and 19 patients
(61%), respectively. Thirteen patients (42%) underwent
contrast arteriography, which yielded positive findings in
11 (85%). Serious complications developed after arteriog-
raphy in three patients (23%), including two large access
site hematomas and one carotid artery rupture during
attempted embolization of a carotid-cavernous fistula.
There was a wide spectrum of imaging findings in these
Fig 1. Kaplan-Meier estimates of survival free of any vascular,
intestinal or uterine complication in 31 patients with clinical diag-
nosis of Ehlers-Danlos syndrome type IV.patients (Fig 2, A to D).
gnetic
JOURNAL OF VASCULAR SURGERY
July 2005100 Oderich et alNonvascular complications. Nonvascular complica-
tions occurred in 20 patients (65%) and consisted of 7
(23%) spontaneous intestinal ruptures, 7 (23%) abdominal
wall hernias, 5 (16%) spontaneous pneumothoraces, 5
(16%) major joint dislocations, and 3 (10%) lens disloca-
tions. Five patients had pregnancy-related complications,
including 3 postpartum hemorrhages (1 requiring hyster-
ectomy), 2 miscarriages, and 1 uterine prolapse. De novo
nonvascular complications occurred in seven patients (24%)
and included five abdominal wall hernias and two postpar-
tum hemorrhages. Overall, 15 patients had both vascular
and nonvascular complications.
Vascular complications. Twenty-four patients (77%)
developed 132 vascular complications (Fig 3). These in-
clude seven patients with diagnosis established solely from
clinical criteria. A history of recent trauma was reported in
only three patients. Eight patients (26%) had a history of
prior interventions at outside institutions, including 2 sub-
clavian artery ligations, 2 chest tube thoracostomies for
hemothoraces, 1 embolization of carotid-cavernous fistula,
1 thoracic aneurysm repair, and 1 stripping of varicose vein.
Of the 132 complications, 63 were symptomatic, 69 were
incidental imaging findings, 78 were present prior or at time
of initial evaluation, and 47 de novo complications occurred
during a median follow-up of 6.3 years (mean, 8.2  6.8
years; range, 0.5 to 26 years). Survival free of vascular
complications was 90% at age 20 years, 39% at 40 years, and
20% at age 60 years (Fig 4).
The nature of 119 vascular complications was deter-
mined using imaging, operative, pathology, or autopsy
findings. Most problems consisted of arterial dissections
and dissecting aneurysms (n 57, 48%) or arterial ruptures
Table II. Radiologic investigation in 29 patients with clin
Modality
Patients w
N  31
Noninvasive studies 29
Echocardiogram 28
Any head 12
CT 8
MRI 8
Any neck 22
US 22
CT 8
Any chest 19
CT 19
MRA 6
Any abdomen 27
US 9
CT 21
MRA 10
Arteriography 13
Cerebral 3
Arch and brachiocephalic arteries 8
Thoracic aorta 7
Abdominal aorta and branches 8
Lower extremity 5
CT, Computed tomography; MRI, magnetic resonance imaging; MRA, mawith or without contained hematomas (n 45, 38%). Truefusiform aneurysms occurred in a minority of patients (n
17, 14%). Three patients had cerebral aneurysms (10%),
and one had a bilateral carotid-cavernous fistula. Four
patients had early onset lower extremity varicose veins.
Cardiac problems included 6 aortic, 2 mitral, and 1 tricus-
pid valve regurgitations. Organ rupture occurred in four
patients and consisted of two spontaneous hemothoraces,
and hepatic and splenic ruptures (one each).
Operative approach. Fifteen patients underwent 30
operative or interventional procedures (Table III), of which
70% were performed on an emergent or urgent basis.
Indications were arterial rupture with active bleeding in 14
(47%), large aneurysm size in 10 (33%), and rapid aneurysm
expansion in 2 (6.7%). Other indications included visceral
or lower extremity ischemia, severe diplopia, and conges-
tive heart failure (one each). There were 15 arterial recon-
structions, including 5 interposition grafts, 4 abdominal
aortic grafts (2 straight and 2 bifurcated), 3 ascending
aortic grafts, 1 thoracic aortic graft, 1 carotid-subclavian
bypass, and 1 femoropopliteal artery bypass. One patient
underwent concomitant aortic valve replacement, and one
patient hadmitral valve replacement. The conduit of choice
was polyester Dacron (DuPont) grafts in 14 cases and
polytetrafluorethylene (PTFE) in one case.
One patient had an unplanned nephrectomy because of
multiple renal arterial tears during attempted renal artery
bypass. Two arterial ruptures were treated with simple
repair and two with ligation. Other procedures included
coil embolizations (n  3), splenectomies (n  2), and
abdominal decompression, video-assisted thoracoscopy,
and graft thrombectomy (n  1 each).
Adjuncts included use of protected clamps or balloon
iagnosis of Ehlers-Danlos syndrome type IV
derwent study Patients with positive findings
% n %
94 22/29 76
90 8/28 29
39 4/12 33
26 2/8 25
26 3/8 38
71 7/22 32
71 7/22 32
26 4/8 50
61 12/19 63
61 10/19 53
19 5/6 83
87 13/27 48
29 7/9 78
68 11/21 52
32 6/10 60
42 11/13 85
10 3/3 100
26 7/8 87
23 5/7 71
26 7/8 87
16 3/5 60
resonance arteriography; US, ultrasound.ical d
ho unocclusion for vascular control and buttressing of arterial
row).
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one patient, the diagnosis of EDS-IV was established 10
years after stripping of saphenous vein.
The mean length of stay was 22 days (range, 3 to 90
days). Three hospital deaths occurred, including one pa-
tient who died en route to the operating room from a
ruptured splenic artery. Two patients died from exsanguinat-
ing hemorrhage from anastomotic rupture and multiple arte-
rial tears. The first patient had multiple prior vascular compli-
cations and had presented with a distal anastomotic rupture 8
years after a carotid-subclavian bypass. Despite an emergent
operation, his tissues were extremely friable and vascular con-
trol could not be obtained. In the second patient, anastomotic
and mediastinal bleeding developed immediately after an as-
cending aortic repair with concomitant aortic valve replace-
ment. Despite attempted re-exploration to surgically control
Fig 2. Wide spectrum of imaging findings in patients
including (A) spontaneous inferior epigastric artery ru
dissected celiac axis with concomitant ruptured splenic
pseudoaneurysm confirmed by operative exploration (arthe bleeding, the patient died in the operating room.Major morbidity occurred after 14 procedures (46%),
and consisted of excessive bleeding in 11 patients (37%),
which required re-exploration in 6 (20%); pulmonary com-
plications in 6 (20%), renal failure in 3 (10%), and cardiac
arrest, brachial plexopathy and prolonged ileus requiring
parenteral nutrition in 1 patient each. The median follow-
up in this group was 7.7 years (mean, 11 years; range, 2 to
22 years). Late graft-related complications occurred after
six (40%) of the 15 arterial reconstructions, and consisted of
4 graft-anastomotic aneurysms, 1 anastomotic rupture, and
1 femoropopliteal graft thrombosis. All graft-related com-
plications required operative repair.
Conservative approach. Forty-two vascular compli-
cations in 15 patients were approached conservatively at the
time of the initial evaluation. These were followed for a
median of 8.6 years (mean, 9 years; range, 0.1 to 22 years),
clinical diagnosis of Ehlers-Danlos syndrome type IV,
, (B) spontaneous hepatic hematoma, (C) ectatic and
aneurysm (arrow), and (D) ruptured ileocolic arterywith
pture
veinwith repeat imaging studies obtained in 13 patients (81%).
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(33%) developed 31 de novo vascular complications. Four
patients (27%) died, two of them from rupture of existing
vascular lesions. The first patient survived splenectomy and
hepatic artery bypass for ruptured hepatic artery, but was
treated conservatively for a carotid artery dissection and
died of carotid artery rupture 3 years later. The second
patient died from an innominate artery rupture 6 years after
Fig 3. Distribution of 132 vascular complications in 24 patients
with a clinical diagnosis of Ehlers-Danlos syndrome type IV.
Fig 4. Kaplan-Meier estimates of survival free of vascular compli-
cations in 31 patients with a clinical diagnosis of Ehlers-Danlos
syndrome type IV. The dotted line denotes 10% standard devia-
tion.being diagnosed with innominate artery dissection. Twopatients died from de novo vascular complications, includ-
ing an intra-abdominal hemorrhage of unknown source
and a thoracic aortic rupture. Overall, six of the 42 existing
vascular complications were associated with further prob-
lems, including 3 ruptures (2 fatal), 3 extensions of the
dissecting process (1 resulting in kidney infarction), and 2
aneurysmal expansions.
Survival and cause of death. The median patient
survival was 54 years of age. The overall patient survival was
98% at age 20 years, 68% at 50 years, and 35% at age 80
years (Fig 5). These figures were significantly decreased
compared with the expected survival for age- and sex-
matched general population controls. Overall, 12 patients
died during the study period. The causes of death were
probably associated with vascular complications in all ex-
cept one patient (cancer). There were 5 confirmed arterial
ruptures, 4 sudden deaths from probable arterial rupture,
and 2 procedure-related deaths. No deaths were associated
with uterine or intestinal complications.
DISCUSSION
EDS-IV is a challenging disorder. Although EDS as a
broad category has an estimated prevalence of one in every
25,000 births, the arterial type is rare and accounts for4%of
EDS patients.1,6 The term vascular or arterial-ecchymotic
EDS was coined by Barabas3-4 in 1967 to describe a subset
of patients with increased vascular fragility. Later in 1975,
Pope et al5 identified the biochemical basis of EDS-IV, a
deficiency in the synthesis or secretion of type III procolla-
gen. The distribution of type III procollagen predomi-
nantly in the skin, walls of blood vessels, and hollow organs
explains its clinical manifestations. The biochemical defect
was later found to result from heterozygous mutations in
theCOL3A1 gene, located in the long arm of chromosome
2 and transmitted as an autosomal dominant condition.
The most recent EDS classification has been simplified
from 11 into six distinct varieties: classical, hypermobility,
vascular, kyphoscoliosis, arthrochalasia, and dermatospar-
axis types.2 The clinical diagnosis of EDS-IV, which is the
vascular form of EDS, can be challenging because of its
rarity and variable and subtle phenotypic features. This may
explain why only 26% of our patients were aware of the
diagnosis before presentation.
We found that excessive bruising and the tendency to
form hematomas is the most frequent sign (97%). The
history of tissue fragility is striking, and 84% of our patients
had prior vascular, intestinal, or uterine complications typ-
ical of EDS-IV. The skin is not hyperextensible, but instead
is thin, translucent, and has highly visible superficial veins,
which are more apparent in the shoulders, chest, and abdo-
men. A characteristic facial appearance, with a thin, deli-
cate, and pinched nose and prominent bones and eyes, was
noticed in 30% of our patients. Severe joint hypermobility is
uncommon; instead, EDS-IV patients typically have milder
laxity involving small joints or even decreased mobility with
contractures. Paradoxically, although the EDS-IV has less
striking clinical features, it is clearly the most malignant type.
r for e
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highly indicative of the disease, laboratory confirmation is
more conclusive and may be advisable.1-2,6 Histology and
electron microscopy often yield nondiagnostic results: arterial
wall thinning, decreased collagen content, and distorted col-
lagen fibril architecture.6 The most reliable study is a direct
Table III. Operative details, indications for repair and clin
Ehlers-Danlos syndrome type IV
Patient
Age/
Sex
Clinical
diagnosis* Biochemical
COL3A1
gene Vascula
1 60M 3 No No Ruptured he
artery aneu
Ruptured fem
2 16F 3 Yes No Carotid-cave
Ruptured car
3 24F 3 Yes No Large multip
aneurysms
4 43M 3 No No Ascending ao
aneurysm
Ruptured dis
aneurysm
Large AAA (
5 47M 2 Yes No Abdominal a
aneurysms
Ruptured fem
6 47M 4 Yes Yes Bilateral rena
with viscer
Ischemia; ab
compartm
7 41F 3 No No Ruptured spl
pseudoane
8 33F 3 Yes No Expanding A
Ruptured spl
Ruptured inf
9 48F 3 Yes Yes Spontaneous
10 43F 3 No No Ruptured sub
Large anasto
11 40M 4 Yes Yes Ruptured ile
12 76M 4 No No Varicose vein
13 37M 2 Yes No Expanding fe
pseudoane
Large innom
pseudoane
Mitral valve r
Ascending ao
Femoropopli
Carotid arter
Large femora
aneurysm
Carotid-subc
rupture
14 26F 3 No No Thoracic aor
15 39M 4 Yes No Ascending ao
M, Male; F, female; AAA, abdominal aortic aneurysm; VAT, video-assisted
*Indicates the number of major clinical criteria, which includes easy bruisi
intestinal and/or uterine fragility.
†Vascular complications and operative procedures are in chronological ordeassessment of procollagen III deficiency by using a gel elec-trophoresis technique. Although this method requires a skin
biopsy specimen, it is more sensitive and has traditionally cost
less than the alternative option of COL3A1 gene analysis.
In addition, one potential problem is that the nature of
theCOL3A1 genemutation does not accurately predict the
type, extent, and prognosis of EDS-IV.1,16 Because
outcome in 15 patients with vascular complications of
plication† Operation
Clinical outcome
(cause of death)
artery/splenic Interposition graft,
splenectomy
Died at age 62
(aortic rupture)
artery aneurysm Interposition graft
fistula Coil embolization Alive at age 24
artery Simple repair with Teflon
sheath
al artery Attempted renal bypass Alive at age 37
Unplanned nephrectomy
issecting Ascending aortic graft Died at age 49
astomotic Aortic-aortic graft
(arterial rupture)
ting) Aortic-biliac graft
and femoral Aortic-bifemoral graft Alive at age 67
artery Interposition graft
ry dissection Abdominal
decompression
Alive at age 52
al
ndrome
rtery with Splenectomy Died at age 44
(arterial rupture)
Aortic-aortic graft Alive at age 55
ein aneurysm Coil embolization
epigastric artery Coil embolization
othorax VAT Died at age 53
(aortic rupture)
Chest tube
an artery Primary ligation Alive at age 69
aneurysm Interposition graft
artery Primary ligation Alive at age 43
Avulsion of varicose veins Died at age 84
(arterial rupture)
l-popliteal Femoropopliteal graft
-subclavian Carotid-subclavian
bypass
itation Mitral valve replacement
issection Ascending aortic graft
raft thrombosis Graft thrombectomy
ture Simple repair
stomotic Interposition graft
anastomotic Attempted control Operative death
eudoaneurysm Aortic-aortic graft Alive at age 48
issection Ascending aortic graft
with AVR
Operative death
coscopy; AVR, aortic valve replacement.
in and translucent skin, characteristic facial features and history of arterial,
ach patient.ical
r com
patic
rysm
oral
rnous
otid
le ren
rtic d
tal an
dissec
ortic
oral
l arte
al
domin
ent sy
enic a
urysm
AA
enic v
erior
hem
clavi
motic
ocolic
s
mora
urysm
inate
urysm
egurg
rtic d
teal g
y rup
l ana
lavian
tic ps
rtic d
thora
ng, thCOL3A1 is a large gene and there are many different
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recognized and may correlate well with specific pheno-
types. Some mutations may be so deleterious as to result in
embryonic death, whereas others could account for minor
degrees of skin fragility, digital hypermobility, and arterial
or intestinal abnormalities.
Previous reports have suggested an autosomal recessive
transmission, but current evidence supports only an auto-
somal dominant pattern.1,6 The implication of a dominant
pattern of inheritance is straightforward: affected individu-
als have 50% chance of passing the mutated gene to each
child. Therefore, genetic counseling is warranted so pa-
tients and their families can be informed regarding the
severity and frequency of complications, its prognosis, and
available reproductive options. Prenatal molecular diagno-
sis requires obstetric procedures, which may carry excessive
risk in these patients. Families should be provided with a
careful discussion on contraception, and reproductive and
pregnancy risks, management of inadvertent pregnancies,
and the options of adoption and artificial insemination with
donor sperm in couples with an affected husband. Patients
are also cautioned to avoid lifestyles with increased poten-
tial for trauma and to use a medical alert bracelet informing
of the diagnosis.
The routine use of imaging studies is controversial.
Some authors advise not pursuing any additional investiga-
tion or surveillance, because a conservative approach will
be adopted irrespectively and undue anxiety would be
created.7 Although there is no definitive evidence that
knowledge of incidental lesions favorably affects survival,
this study shows that the diagnostic yield of noninvasive
studies is very high (76%) and that vascular lesions are often
incidental findings (50%). In addition, six patients with
incidental lesions treated conservatively had an adverse
outcome, including two deaths from arterial rupture.
Therefore, we continue to recommend echocardiography,
carotid artery ultrasound scans, and noninvasive imaging of
Fig 5. Comparison of Kaplan-Meier estimates of overall survival
in 31 patients with a clinical diagnosis of Ehlers-Danlos syndrome
type IV and in age- and sex-matched controls. The dotted line
denotes 10% standard deviation.the abdominal aorta by ultrasound, computed tomography(CT), or magnetic resonance angiography (MRA) during
the initial evaluation. We prefer CT angiography of the
chest and abdomen.
Arteriography has been associated with a high compli-
cation rate and was used mostly in the beginning of our
experience.6-7,12 Arterial tears can occur in association with
the access site or in remote locations, as exemplified by one
of our patients, in whom a carotid artery tear developed
during selective internal carotid artery catheterization.7,13
The risk-benefit ratio for any invasive diagnostic or thera-
peutic study should be carefully assessed. We currently
advocate arteriography when arterial embolization is con-
sidered. In addition, these issues underscore the value of
establishing the diagnosis as early as possible so procedures
that carry high risk of complications can be avoided.
In this group of patients, vascular complications af-
fected medium and large-sized arteries in many anatomic
locations. Some series suggested that vascular lesions tend
to affect arteries near the shoulder and hip joint, but we
found that essentially all vascular territories could be af-
fected, with most lesions located in the aorta and its prox-
imal branches or within the visceral and renal arteries. Most
complications were spontaneous, and only three patients
reported a history of recent trauma.
The exact nature of vascular lesions has also been a
matter of debate and confusion in the literature.17 We
found that most vascular complications were either arterial
dissections, often associated with aneurysmal degeneration,
or arterial tears resulting in contained hematomas, false
aneurysms, or intracavitary bleeding. It is possible that
some dissections actually represented subintimal hemato-
mas associated with intimal tears. We agree with other
reports that most “aneurysms” described in the literature
probably represent false aneurysms17; however, a small
group of our patients (14%) did have true fusiform aneu-
rysms.
Vascular complications shortened survival in patients
with EDS-IV. Intestinal rupture was not associated with
late deaths in this study. Our findings are in agreement with
the landmark study by Pepin et al,8 who found that 92% of
late deaths in a cohort of 220 index patients were from
vascular complications.8 In addition, the median survival
(48 vs 54 years of age) and overall patient survival at age 60
years (55% vs 68%) were similar in both studies. Finally, the
Pepin et al study found decreased survival in affected family
members compared with index patients (33% vs 55% at age
60 years, respectively), a finding that could not be con-
firmed in our study because of incomplete data.8
The traditional recommendation when dealing with
vascular complications of EDS-IV has been a conservative
approach, with operative treatment reserved for patients
presenting with imminent or frank life-threatening bleed-
ing.6-7 However, surgeons are occasionally faced with the
dilemma of whether the elective repair of a large asymptom-
atic aneurysm is indicated. Decision making can be difficult
because EDS-IV patients have a very heterogeneous spec-
trum of disease. Some patients have an aggressive formwith
excessive tissue fragility, whereas others respond as would a
JOURNAL OF VASCULAR SURGERY
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reconstruction without significant problems. Overall, we
continue to exercise caution when indicating elective opera-
tions and advise a higher threshold for operating on non-
ruptured dissecting aneurysms. Finally, one should be par-
ticularly cautious not to indicate avoidable elective
operations (eg, avulsion of varicose vein) that carry exces-
sive risk of complications, especially in patients with spo-
radic disease and mild phenotype.
To optimize clinical outcome, the surgeon should be
aware of the diagnosis before an operation. Precautionary
measures include gentle, atraumatic, and delicate handling
of tissues. Normal handling of arteries is bound to induce
more arterial tears. Retractors should be placed carefully to
avoid damaging adjacent bowel or mesentery. Use of soft,
protected arterial clamps, balloon occlusion, or an ortho-
pedic tourniquet is preferable to standard arterial clamps.
The surgeon should select the least complicated and most
expeditious technique of repair. Arterial ligation is an ex-
cellent choice whenever possible without compromising
blood supply (eg, subclavian artery). The use of umbilical
tape over a PTFE sheath has been described as a useful
technique to prevent sutures from cutting into the arterial
wall.7
Simple arterial repairs are occasionally feasible. How-
ever, central arterial complications often require arterial
reconstruction with prosthetic grafts. In these cases, use of
autologous vein is contraindicated. The anastomosis
should be tensionless and buttressed with Teflon felt strips
or pledgets. However, despite the use of several of these
techniques, a substantial number of our patients developed
operative bleeding complications (37%) and late graft-anas-
tomotic problems (40%).
Finally, there are currently no reports on the use of
stent grafts to treat vascular complications of EDS-IV.
Specific concerns include the introduction of large-bore
devices and the potential risk of arterial rupture remote to
the access site. In our opinion, endovascular treatment
should be limited to coil embolization of ruptured arteries.
Although our findings are in agreement with previous
reports, some potential limitations of our study merit dis-
cussion:
● In seven patients, the diagnosis was established solely
from clinical criteria, without biochemical confirma-
tion; it is possible that some of these cases represented
EDS-like disorders with distinct yet unidentified bio-
chemical mechanisms.
● Because the study was retrospective and spanned three
decades, the exact circumstances involved in the deci-
sion making (eg, operation vs conservative approach,
choice of repair) are difficult to determine.
● During this period diagnostic modalities, surgical ex-
perience, techniques, and perioperative care varied
considerably.
● Despite being one of the largest surgical series, the
numbers are too small to enable subgroup analysis.● This series reflects a referral population to a tertiary
care center and may be biased toward more severely
affected EDS-IV patients and not fully representative
of all EDS-IV patients in the general population.
There is currently no effective medical treatment that
can predictably decrease the risk of vascular complications
and increase life expectancy in patients with EDS-IV. How-
ever, the diagnosis should be considered in young patients
with unexplained arterial rupture or dissections, particularly
if there is a family history for vascular, intestinal, or uterine
complications. Arteriography should be avoided whenever
possible, but noninvasive imaging studies (echocardio-
gram, carotid and abdominal ultrasound scanning, CT or
MRA) provide an excellent means of evaluating the pres-
ence and extent of complications. Operative treatment is
indicated in patients with frank or imminent life-threatening
bleeding. Although operative mortality was not excessively
high in this study, the incidence of postoperative bleeding
complications and late graft-related problems was signifi-
cant. In addition, despite successful repair of vascular com-
plications, survival was shortened because of secondary
vascular or graft-related complications.
CONCLUSION
Ehlers-Danlos syndrome type IV, the vascular type, is a
rare connective tissue disorder caused by type III procolla-
gen deficiency due to COL3A1 gene mutation. Clinical
diagnosis is established from at least two of four major
clinical criteria: thin, translucent skin; arterial, intestinal, or
uterine fragility or rupture; extensive bruising; and charac-
teristic facial appearance. Although the presence of two
major clinical criteria is highly indicative of EDS-IV, labo-
ratory testing for procollagen III deficiency is strongly
recommended. Results of biochemical and gene mutation
analysis may take months, and operative therapy should not
be delayed if indicated. Initial imaging evaluation includes
echocardiogram, carotid ultrasound, and noninvasive im-
aging of the chest and abdomen. Arteriography is indicated
if coil embolization is considered.
Follow-up includes annual physical examination, ca-
rotid and abdominal ultrasound for asymptomatic patients,
and noninvasive imaging of chest and abdomen if inciden-
tal findings are present. Patients treated conservatively for
aneurysm need close follow-up (3 to 6 months) to assess
expansion rate. Vascular complications typically include
spontaneous arterial rupture, dissection, and dissecting an-
eurysms.
Patients with asymptomatic complications aremanaged
conservatively. Patients with frank bleeding require emer-
gent operative repair or catheter-directed embolization.
The treatment of minimally symptomatic aneurysms is con-
troversial, and data do not allow definitive recommenda-
tions. We generally treat these conservatively unless rapid
aneurysm expansion or aneurysm size indicates an impend-
ing rupture.
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